{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["QSPR", "Tylophora indica", "alkaloids", "anti-proliferative", "anticancer activity", "kinase inhibition", "phenanthroindolizidine", "quantitative structure properties relationship", "receptor docking", "tylophorines"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35631719", "DateRevised": {"Year": "2022", "Month": "07", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "05", "Day": "12"}], "Language": ["eng"], "ELocationID": ["1295", "10.3390/plants11101295"], "Journal": {"ISSN": "2223-7747", "JournalIssue": {"Volume": "11", "Issue": "10", "PubDate": {"Year": "2022", "Month": "May", "Day": "12"}}, "Title": "Plants (Basel, Switzerland)", "ISOAbbreviation": "Plants (Basel)"}, "ArticleTitle": "In Vitro Anti-Proliferative, and Kinase Inhibitory Activity of Phenanthroindolizidine Alkaloids Isolated from <i>Tylophora indica</i>.", "Abstract": {"AbstractText": ["The phenanthroindolizidine alkaloid (-)-tylophorine has been reported for its significant anticancer activity working through different biomechanistic pathways. The current study aimed to evaluate the anticancer activity of phenanthroindolizidine alkaloids isolated from <i>Tylophora indica</i>. Six phenanthroindolizidine alkaloid (compounds <b>1</b>-<b>6</b>) in addition to septicine (<b>7</b>), chlorogenic acid (<b>8</b>), and chlorogenic acid methyl ester (<b>9</b>) were isolated from <i>Tylophora indica</i> using different chromatographic techniques including vacuum liquid chromatography (VLC) and preparative high performance liquid chromatography (HPLC). The isolated compounds structures' were determined using various spectro-analytical techniques, i.e., <sup>1</sup>H-NMR, <sup>13</sup>C-NMR, and mass spectrometry. The isolates' structural stereochemistry and structural geometries were determined with the help of chiroptical techniques together with comparisons with the available standard samples. The in vitro anti-proliferative activity on three different cell lines, MCF-7, HepG2, and HCT-116 were evaluated. Among all the isolated compounds, tylophorinidine (<b>5</b>) was the most active cytotoxic agent with the lowest IC<sub>50</sub> values at 6.45, 4.77, and 20.08 \u03bcM against MCF-7, HepG2, and HCT-116 cell lines, respectively. The bioactivities were also validated by the in vitro kinase receptors inhibition assay. Compound (<b>5</b>) also exhibited the highest activity with lowest IC<sub>50</sub> values (0.6 and 1.3 \u03bcM against the Aurora-A and Aurora-B enzymes, respectively), as compared with all the isolated alkaloidal products. The structure activity relationship on the molecular properties, molecular attributes, and bioactivity levels were analyzed, interrelated, and the molecular docking studies on two different receptors, Aurora-A and Aurora-B, were determined, which provided the confirmations of the bioactivity with receptor-ligand geometric disposition, energy requirements, lipophilicity, and detailed the binding pharmacophore involvements responsible for bioactivity elicitations."]}, "AuthorList": [{"Identifier": ["0000-0001-8841-9786"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, College of Pharmacy, Jouf University, Sakaka 72341, Saudi Arabia."}], "LastName": "Mostafa", "ForeName": "Ehab M", "Initials": "EM"}, {"Identifier": ["0000-0003-2896-6790"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, Qassim University, Buraydah 51452, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Department of Pharmacognosy and Medicinal Plants, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt."}], "LastName": "Mohammed", "ForeName": "Hamdoon A", "Initials": "HA"}, {"Identifier": ["0000-0003-0979-556X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, College of Pharmacy, Jouf University, Sakaka 72341, Saudi Arabia."}], "LastName": "Musa", "ForeName": "Arafa", "Initials": "A"}, {"Identifier": ["0000-0001-9035-5638"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, College of Pharmacy, Jouf University, Sakaka 72341, Saudi Arabia."}], "LastName": "Abdelgawad", "ForeName": "Mohamed A", "Initials": "MA"}, {"Identifier": ["0000-0002-9820-4022"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, College of Pharmacy, Jouf University, Sakaka 72341, Saudi Arabia."}], "LastName": "Al-Sanea", "ForeName": "Mohammad M", "Initials": "MM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, Qassim University, Buraydah 51452, Saudi Arabia."}], "LastName": "Almahmoud", "ForeName": "Suliman A", "Initials": "SA"}, {"Identifier": ["0000-0002-9179-4373"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy and Medicinal Plants, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt."}, {"Identifier": [], "Affiliation": "Department of Pharmacy Practice, College of Pharmacy, Al Maarefa University, Ad Diriya 13713, Saudi Arabia."}], "LastName": "Ghoneim", "ForeName": "Mohammed M", "Initials": "MM"}, {"Identifier": ["0000-0001-7510-8428"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, College of Pharmacy, Jouf University, Sakaka 72341, Saudi Arabia."}], "LastName": "Gomaa", "ForeName": "Hesham A M", "Initials": "HAM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Basic Sciences, Faculty of Oral and Dental Medicine, Nahda University, Beni-Suef 62511, Egypt."}], "LastName": "Rahman", "ForeName": "Fatema El-Zahraa S Abdel", "Initials": "FESA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutics, College of Pharmacy, Jouf University, Sakaka 72341, Saudi Arabia."}], "LastName": "Shalaby", "ForeName": "Khaled", "Initials": "K"}, {"Identifier": ["0000-0003-4025-8586"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakaka 72388, Saudi Arabia."}], "LastName": "Selim", "ForeName": "Samy", "Initials": "S"}, {"Identifier": ["0000-0003-0185-0149"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, Qassim University, Buraydah 51452, Saudi Arabia."}], "LastName": "Khan", "ForeName": "Riaz A", "Initials": "RA"}], "GrantList": [{"GrantID": "DSR-2021-01-0102", "Agency": "Deanship of Scientific Research at Jouf University", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Plants (Basel)", "NlmUniqueID": "101596181", "ISSNLinking": "2223-7747"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Poste G., Fidler I.J. The pathogenesis of cancer metastasis. Nature. 1980;283:139\u2013146. doi: 10.1038/283139a0.", "ArticleIdList": ["10.1038/283139a0", "6985715"]}, {"Citation": "Institute N.C. Type of Cancers.  [(accessed on 25 March 2022)]; Available online:  https://www.cancer.gov/types."}, {"Citation": "Baskar R., Lee K.A., Yeo R., Yeoh K.-W. Cancer and radiation therapy: Current advances and future directions. Int. J. Med. Sci. 2012;9:193. doi: 10.7150/ijms.3635.", "ArticleIdList": ["10.7150/ijms.3635", "PMC3298009", "22408567"]}, {"Citation": "Wang J.J., Lei K.F., Han F. Tumor microenvironment: Recent advances in various cancer treatments. Eur. Rev. Med. Pharmacol. Sci. 2018;22:3855\u20133864.", "ArticleIdList": ["29949179"]}, {"Citation": "Ji H., Li X., Zhang H. Natural products and drug discovery: Can thousands of years of ancient medical knowledge lead us to new and powerful drug combinations in the fight against cancer and dementia? EMBO Rep. 2009;10:194\u2013200. doi: 10.1038/embor.2009.12.", "ArticleIdList": ["10.1038/embor.2009.12", "PMC2658564", "19229284"]}, {"Citation": "Gurib-Fakim A. Medicinal plants: Traditions of yesterday and drugs of tomorrow. Mol. Asp. Med. 2006;27:1\u201393. doi: 10.1016/j.mam.2005.07.008.", "ArticleIdList": ["10.1016/j.mam.2005.07.008", "16105678"]}, {"Citation": "Safarzadeh E., Shotorbani S.S., Baradaran B. Herbal medicine as inducers of apoptosis in cancer treatment. Adv. Pharm. Bull. 2014;4:421.", "ArticleIdList": ["PMC4213780", "25364657"]}, {"Citation": "Cragg G.M., Grothaus P.G., Newman D.J. Impact of natural products on developing new anti-cancer agents. Chem. Rev. 2009;109:3012\u20133043. doi: 10.1021/cr900019j.", "ArticleIdList": ["10.1021/cr900019j", "19422222"]}, {"Citation": "Zhang Y.-W., Kong X.-Y., Wang J.-H., Du G.-H. Natural Small Molecule Drugs from Plants. Springer; Berlin/Heidelberg, Germany: 2018. Vinblastine and vincristine; pp. 551\u2013557."}, {"Citation": "Ghesquieres H., Casasnovas O., Nicolas-Virelizier E., Laurent D.G., Delwail V., Touati M., Le Du K., Morschhauser F., Bonnet C., Waultier-Rascalou A., et al. Prednisone, vinblastine, doxorubicin and bendamustine (PVAB) regimen in first line therapy for older patients with advanced-stage classical Hodgkin lymphoma: Results of a Prospective Multicenter Phase II Trial of the Lymphoma Study Association (LYSA) Blood. 2019;134:2832. doi: 10.1182/blood-2019-129016.", "ArticleIdList": ["10.1182/blood-2019-129016"]}, {"Citation": "Vergote I., Scambia G., O\u2019Malley D.M., Van Calster B., Park S.-Y., Del Campo J.M., Meier W., Bamias A., Colombo N., Wenham R.M., et al. Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): A randomised, double-blind, phase 3 trial. Lancet Oncol. 2019;20:862\u2013876. doi: 10.1016/S1470-2045(19)30178-0.", "ArticleIdList": ["10.1016/S1470-2045(19)30178-0", "31076365"]}, {"Citation": "Bishop J.F., Dewar J., Toner G.C., Tattersall M.H., Olver I.N., Ackland S., Kennedy I., Goldstein D., Gurney H., Walpole E., et al. Paclitaxel as first-line treatment for metastatic breast cancer. The Taxol Investigational Trials Group, Australia and New Zealand. Oncology. 1997;11:19\u201323.", "ArticleIdList": ["9144686"]}, {"Citation": "Broxterman H.J., Lankelma J., Hoekman K. Resistance to cytotoxic and anti-angiogenic anticancer agents: Similarities and differences. Drug Resist. Update. 2003;6:111\u2013127. doi: 10.1016/S1368-7646(03)00026-8.", "ArticleIdList": ["10.1016/S1368-7646(03)00026-8", "12860459"]}, {"Citation": "Buyel J.F. Plants as sources of natural and recombinant anti-cancer agents. Biotechnol. Adv. 2018;36:506\u2013520. doi: 10.1016/j.biotechadv.2018.02.002.", "ArticleIdList": ["10.1016/j.biotechadv.2018.02.002", "29408560"]}, {"Citation": "Mohammed H.A., Khan R.A., Abdel-Hafez A.A., Abdel-Aziz M., Ahmed E., Enany S., Mahgoub S., Al-Rugaie O., Alsharidah M., Aly M.S.A., et al. Profiling, In Vitro and In Silico Anti-Microbial and Anti-Cancer Activity Evaluations and Staph GyraseB and h-TOP-II\u03b2 Receptor-Docking Studies of Major Constituents of Zygophyllum coccineum L. Aqueous-Ethanolic Extract and Its Subsequent Fra. Molecules. 2021;26:577. doi: 10.3390/molecules26030577.", "ArticleIdList": ["10.3390/molecules26030577", "PMC7866194", "33499325"]}, {"Citation": "Mohammed H.A., Abd El-Wahab M.F., Shaheen U., Mohammed A.E.-S.I., Abdalla A.N., Ragab E.A. Isolation, Characterization, Complete Structural Assignment, and Anticancer Activities of the Methoxylated Flavonoids from Rhamnus disperma Roots. Molecules. 2021;26:5827. doi: 10.3390/molecules26195827.", "ArticleIdList": ["10.3390/molecules26195827", "PMC8510169", "34641372"]}, {"Citation": "Mohammed H.A., Al-Omar M.S., Khan R.A., Mohammed S.A.A., Qureshi K.A., Abbas M.M., Al Rugaie O., Abd-Elmoniem E., Ahmad A.M., Kandil Y.I. Chemical Profile, Antioxidant, Antimicrobial, and Anticancer Activities of the Water-Ethanol Extract of Pulicaria undulata Growing in the Oasis of Central Saudi Arabian Desert. Plants. 2021;10:1811. doi: 10.3390/plants10091811.", "ArticleIdList": ["10.3390/plants10091811", "PMC8472717", "34579344"]}, {"Citation": "Mileva M., Dimitrova L., Popova M., Bankova V., Krastev D., Najdenski H., Zhelev Z., Aoki I., Bakalova R. Redox-modulation, Suppression of \u201cOncogenic\u201d Superoxide and Induction of Apoptosis in Burkitt\u2019s Lymphoma Cells Using Geum urbanum L. Extracts. Int. J. Bioautom. 2021;25:315. doi: 10.7546/ijba.2021.25.4.000795.", "ArticleIdList": ["10.7546/ijba.2021.25.4.000795"]}, {"Citation": "Mohammed H.A., Ali H.M., Qureshi K.A., Alsharidah M., Kandil Y.I., Said R., Mohammed S.A.A., Al-Omar M.S., Al Rugaie O., Abdellatif A.A.H., et al. Comparative Phytochemical Profile and Biological Activity of Four Major Medicinal Halophytes from Qassim Flora. Plants. 2021;10:2208. doi: 10.3390/plants10102208.", "ArticleIdList": ["10.3390/plants10102208", "PMC8538075", "34686017"]}, {"Citation": "Gezici S., \u015eekero\u011flu N. Current perspectives in the application of medicinal plants against cancer: Novel therapeutic agents. Anti-Cancer Agents Med. Chem. (Former. Curr. Med. Chem. Agents) 2019;19:101\u2013111. doi: 10.2174/1871520619666181224121004.", "ArticleIdList": ["10.2174/1871520619666181224121004", "30582485"]}, {"Citation": "Twilley D., Rademan S., Lall N. A review on traditionally used South African medicinal plants, their secondary metabolites and their potential development into anticancer. J. Ethnopharmacol. 2020;261:113101. doi: 10.1016/j.jep.2020.113101.", "ArticleIdList": ["10.1016/j.jep.2020.113101", "32562876"]}, {"Citation": "Rajabi S., Maresca M., Yumashev A.V., Choopani R., Hajimehdipoor H. The most competent plant-derived natural products for targeting Apoptosis in cancer therapy. Biomolecules. 2021;11:534. doi: 10.3390/biom11040534.", "ArticleIdList": ["10.3390/biom11040534", "PMC8066452", "33916780"]}, {"Citation": "Saraswati S., Kanaujia P.K., Kumar S., Kumar R., Alhaider A.A. Tylophorine, a phenanthraindolizidine alkaloid isolated from Tylophora indica exerts antiangiogenic and antitumor activity by targeting vascular endothelial growth factor receptor 2\u2013mediated angiogenesis. Mol. Cancer. 2013;12:1\u201316. doi: 10.1186/1476-4598-12-82.", "ArticleIdList": ["10.1186/1476-4598-12-82", "PMC3733984", "23895055"]}, {"Citation": "Yang C.-W., Lee Y.-Z., Hsu H.-Y., Wu C.-M., Chang H.-Y., Chao Y.-S., Lee S.-J. c-Jun-mediated anticancer mechanisms of tylophorine. Carcinogenesis. 2013;34:1304\u20131314. doi: 10.1093/carcin/bgt039.", "ArticleIdList": ["10.1093/carcin/bgt039", "23385061"]}, {"Citation": "Zhang S., Wei L., Bastow K., Zheng W., Brossi A., Lee K.-H., Tropsha A. Antitumor agents 252. Application of validated QSAR models to database mining: Discovery of novel tylophorine derivatives as potential anticancer agents. J. Comput. Aided Mol. Des. 2007;21:97\u2013112. doi: 10.1007/s10822-007-9102-6.", "ArticleIdList": ["10.1007/s10822-007-9102-6", "PMC2754562", "17340042"]}, {"Citation": "Wu C.-M., Yang C.-W., Lee Y.-Z., Chuang T.-H., Wu P.-L., Chao Y.-S., Lee S.-J. Tylophorine arrests carcinoma cells at G1 phase by downregulating cyclin A2 expression. Biochem. Biophys. Res. Commun. 2009;386:140\u2013145. doi: 10.1016/j.bbrc.2009.05.138.", "ArticleIdList": ["10.1016/j.bbrc.2009.05.138", "19501048"]}, {"Citation": "Joa H., Bla\u017eevi\u0107 T., Grojer C., Zeller I., Heiss E.H., Atanasov A.G., Feldler I., Gruzdaitis P., Czaloun C., Proksch P., et al. Tylophorine reduces protein biosynthesis and rapidly decreases cyclin D1, inhibiting vascular smooth muscle cell proliferation in vitro and in organ culture. Phytomedicine. 2019;60:152938. doi: 10.1016/j.phymed.2019.152938.", "ArticleIdList": ["10.1016/j.phymed.2019.152938", "31078367"]}, {"Citation": "Lin J.-C., Yang S.-C., Hong T.-M., Yu S.-L., Shi Q., Wei L., Chen H., Yang P., Lee K. Phenanthrene-based tylophorine-1 (PBT-1) inhibits lung cancer cell growth through the Akt and NF-\u03baB pathways. J. Med. Chem. 2009;52:1903\u20131911. doi: 10.1021/jm801344j.", "ArticleIdList": ["10.1021/jm801344j", "PMC2670969", "19284764"]}, {"Citation": "Herbpathy  Tylophora Indica Herb Uses, Benefits, Cures, Side Effects, Nutrients.  [(accessed on 25 March 2022)].  Available online:  https://herbpathy.com/Uses-and-Benefits-of-Tylophora-Indica-Cid1640."}, {"Citation": "Tariq A., Mehmood T., Ahmad M., Sahar U., Mushtaq S., Zafar M. Comparative assessment of genetic diversity among the Asclepiadaceous species using randomly amplified polymorphic DNA (RAPD) markers and numerical taxonomy system (NTSYS) cluster analysis. J. Med. Plants Res. 2014;8:88\u201394."}, {"Citation": "Phillipson J.D., Tezcan I., Hylands P.J. Alkaloids of Tylophora species from Sri Lanka. Planta Med. 1974;25:301\u2013309. doi: 10.1055/s-0028-1097948.", "ArticleIdList": ["10.1055/s-0028-1097948", "4850478"]}, {"Citation": "Nazar S., Hussain M.A., Khan A., Muhammad G., Bukhari S.N.A. Alkaloid-rich plant Tylophora indica; current trends in isolation strategies, chemical profiling and medicinal applications. Arab J. Chem. 2020;13:6348\u20136365. doi: 10.1016/j.arabjc.2020.05.037.", "ArticleIdList": ["10.1016/j.arabjc.2020.05.037"]}, {"Citation": "Jeyachandran R., Bastin M. In-vitro propagation of Tylophora ovata (Lind.) Hook. ex. Steud-an important medicinal plant. Int. J. Pharm. Life Sci. 2014;5:1083\u20131086."}, {"Citation": "Devi P., Singh R., Kumar R., Kumar M., Awasthi K.K., Singh T., Awasthi G. Alteration of Media Enables Efficient In-vitro Regeneration in Antamool (Tylophora indica): AThreatened Medicinal Plant. Gorteria. 2021;34:50\u201360."}, {"Citation": "Karpov O.A., Fearnley G.W., Smith G.A., Kankanala J., McPherson M.J., Tomlinson D.C., Harrison M.A., Ponnambalam S. Receptor tyrosine kinase structure and function in health and disease. AIMS Biophys. 2015;2:476\u2013502. doi: 10.3934/biophy.2015.4.476.", "ArticleIdList": ["10.3934/biophy.2015.4.476"]}, {"Citation": "Roskoski R., Jr. The ErbB/HER family of protein-tyrosine kinases and cancer. Pharmacol. Res. 2014;79:34\u201374. doi: 10.1016/j.phrs.2013.11.002.", "ArticleIdList": ["10.1016/j.phrs.2013.11.002", "24269963"]}, {"Citation": "Van Meerloo J., Kaspers G.J.L., Cloos J. Cell sensitivity assays: The MTT assay. Methods Mol. Biol. 2011;731:237\u2013245.", "ArticleIdList": ["21516412"]}, {"Citation": "Dhiman M., Khanna A., Manju S. A new phenanthroindolizidine alkaloid from Tylophora indica. Chem. Papers. 2013;67:245\u2013248. doi: 10.2478/s11696-012-0265-9.", "ArticleIdList": ["10.2478/s11696-012-0265-9"]}, {"Citation": "Liu J., He Y., Zhang D., Cai Y., Zhang C., Zhang P., Zhu H., Xu N., Liang S. In vitro anticancer effects of two novel phenanthroindolizidine alkaloid compounds on human colon and liver cancer cells. Mol. Med. Rep. 2017;16:2595\u20132603. doi: 10.3892/mmr.2017.6879.", "ArticleIdList": ["10.3892/mmr.2017.6879", "PMC5548052", "28677760"]}, {"Citation": "Ying Z.Y., Shi H.X., De Quan Y.U., Shan Y.U.S. Antitumor alkaloids isolated from Tylophora ovata. J. Integr. Plant Biol. 2002;44:349."}, {"Citation": "Comins D.L., Morgan L.A. N-acyldihydropyridones as synthetic intermediates. Synthesis of (\u00b1)-septicine and (\u00b1)-tylophorine. Tetrahedron Lett. 1991;32:5919\u20135922. doi: 10.1016/S0040-4039(00)79426-3.", "ArticleIdList": ["10.1016/S0040-4039(00)79426-3"]}, {"Citation": "Pauli G.F., Kuczkowiak U., Nahrstedt A. Solvent effects in the structure dereplication of caffeoyl quinic acids. Magn. Reson. Chem. 1999;37:827\u2013836. doi: 10.1002/(SICI)1097-458X(199911)37:11<827::AID-MRC568>3.0.CO;2-W.", "ArticleIdList": ["10.1002/(SICI)1097-458X(199911)37:11<827::AID-MRC568>3.0.CO;2-W"]}, {"Citation": "Ida Y., Satoh Y., Ohtsuka M., Nagasao M., Shoji J. Phenolic constituents of Phellodendron amurense bark. Phytochemistry. 1993;35:209\u2013215. doi: 10.1016/S0031-9422(00)90536-3.", "ArticleIdList": ["10.1016/S0031-9422(00)90536-3"]}, {"Citation": "Musa A., Al-Sanea M.M., Alotaibi N.H., Alnusaire T.S., Ahmed S.R., Mostafa E.M. In silico study, protein kinase inhibition and antiproliferative potential of flavonoids isolated from Bassia eriophora (Schrad.) growing in KSA. Indian J. Pharm. Educ. Res. 2021;55:483\u2013490. doi: 10.5530/ijper.55.2.86.", "ArticleIdList": ["10.5530/ijper.55.2.86"]}, {"Citation": "Mohammed H.A., Al-Omar M.S., El-Readi M.Z., Alhowail A.H., Aldubayan M.A., Abdellatif A.A.H. Formulation of Ethyl Cellulose Microparticles Incorporated Pheophytin A Isolated from Suaeda vermiculata for Antioxidant and Cytotoxic Activities. Molecules. 2019;24:1501. doi: 10.3390/molecules24081501.", "ArticleIdList": ["10.3390/molecules24081501", "PMC6514815", "30999569"]}, {"Citation": "Mostafa E.M. Exploration of aurora B and cyclin-dependent kinase 4 inhibitors isolated from Scorzonera tortuosissima boiss. and their docking studies. Pharmacogn. Mag. 2020;16:258."}, {"Citation": "Musa A., Elmaidomy A.H., Sayed A.M., Alzarea S.I., Al-Sanea M.M., Mostafa E.M., Hendawy O.M., Abdelgawad M.A., Youssif K.A., Refaat H., et al. Cytotoxic Potential, Metabolic Profiling, and Liposomes of Coscinoderma sp. Crude Extract Supported by in silico Analysis. Int. J. Nanomed. 2021;16:3861. doi: 10.2147/IJN.S310720.", "ArticleIdList": ["10.2147/IJN.S310720", "PMC8187037", "34113103"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "4", "Day": "19"}, {"Year": "2022", "Month": "5", "Day": "7"}, {"Year": "2022", "Month": "5", "Day": "10"}, {"Year": "2022", "Month": "5", "Day": "28", "Hour": "1", "Minute": "39"}, {"Year": "2022", "Month": "5", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "5", "Day": "29", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "5", "Day": "12"}], "PublicationStatus": "epublish", "ArticleIdList": ["35631719", "PMC9144581", "10.3390/plants11101295", "plants11101295"]}}], "PubmedBookArticle": []}